{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:47:10Z","timestamp":1788583630529,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11916-026-01472-w","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:00:34Z","timestamp":1773756034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Selective NaV1.8 Inhibition for Pain Management: Current Evidence and Future Potential of Suzetrigine"],"prefix":"10.1007","volume":"30","author":[{"given":"Alaa","family":"Abd-Elsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Kohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Zahid","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"9","key":"1472_CR1","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976\u201382. https:\/\/doi.org\/10.1097\/j.pain.0000000000001939","journal-title":"Pain"},{"key":"1472_CR2","doi-asserted-by":"publisher","unstructured":"Palecek J, Paleckova V, Willis WD. The roles of pathways in the spinal cord lateral and dorsal funiculi in signaling nociceptive somatic and visceral stimuli in rats. Pain. 2002;96(3):297\u2013307. https:\/\/doi.org\/10.1016\/S0304-3959(01)00459-6","DOI":"10.1016\/S0304-3959(01)00459-6"},{"key":"1472_CR3","doi-asserted-by":"publisher","unstructured":"Bannister K, Dickenson AH. The plasticity of descending controls in pain: translational probing. J Physiol. 2017;595(13):4159\u20134166. https:\/\/doi.org\/10.1113\/JP274165","DOI":"10.1113\/JP274165"},{"key":"1472_CR4","doi-asserted-by":"publisher","unstructured":"Vase L, Wager TD, Eccleston C. Opportunities for chronic pain self-management: core psychological principles and neurobiological underpinnings. Lancet. 2025;405(10491):1781\u20131790. https:\/\/doi.org\/10.1016\/S0140-6736(25)00404-0","DOI":"10.1016\/S0140-6736(25)00404-0"},{"key":"1472_CR5","doi-asserted-by":"publisher","unstructured":"Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082\u20132097. https:\/\/doi.org\/10.1016\/S0140-6736(21)00393-7","DOI":"10.1016\/S0140-6736(21)00393-7"},{"issue":"4","key":"1472_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/ALN.0b013e3181c43103","volume":"112","author":"American Society of Anesthesiologists Task Force on Chronic Pain Management","year":"2010","unstructured":"American Society of Anesthesiologists Task Force on Chronic Pain Management. American Society of Regional Anesthesia and Pain Medicine. Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology. 2010;112(4):810\u201333. https:\/\/doi.org\/10.1097\/ALN.0b013e3181c43103","journal-title":"Anesthesiology"},{"issue":"2","key":"1472_CR7","first-page":"187","volume":"112","author":"R Sokol","year":"2025","unstructured":"Sokol R, Grossman E, Bourgery R. Nonopioid pharmacologic management of chronic noncancer pain. Am Fam Physician. 2025;112(2):187\u201396.","journal-title":"Am Fam Physician"},{"key":"1472_CR8","doi-asserted-by":"publisher","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R, CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States., 2022. MMWR Recomm Rep. 2022;71(3):1\u201395. https:\/\/doi.org\/10.15585\/mmwr.rr7103a1","DOI":"10.15585\/mmwr.rr7103a1"},{"issue":"5","key":"1472_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41583-021-00444-w","volume":"22","author":"G Goodwin","year":"2021","unstructured":"Goodwin G, McMahon SB. The physiological function of different voltage-gated sodium channels in pain. Nat Rev Neurosci. 2021;22(5):263\u201374. https:\/\/doi.org\/10.1038\/s41583-021-00444-w","journal-title":"Nat Rev Neurosci"},{"key":"1472_CR10","doi-asserted-by":"publisher","first-page":"1573254","DOI":"10.3389\/fphar.2025.1573254","volume":"16","author":"R Chen","year":"2025","unstructured":"Chen R, Liu Y, Qian L, Yi M, Yin H, Wang S, Xiang B. Sodium channels as a new target for pain treatment. Front Pharmacol. 2025;16:1573254. https:\/\/doi.org\/10.3389\/fphar.2025.1573254","journal-title":"Front Pharmacol"},{"issue":"12","key":"1472_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-020-00415-2","volume":"16","author":"M Alsaloum","year":"2020","unstructured":"Alsaloum M, Higerd GP, Effraim PR, Waxman SG. Status of peripheral sodium channel blockers for non-addictive pain treatment. Nat Rev Neurol. 2020;16(12):689\u2013705. https:\/\/doi.org\/10.1038\/s41582-020-00415-2","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"1472_CR12","doi-asserted-by":"publisher","first-page":"e23083","DOI":"10.1371\/journal.pone.0023083","volume":"6","author":"S Lolignier","year":"2011","unstructured":"Lolignier S, Amsalem M, Maingret F, Padilla F, Gabriac M, Chapuy E, Eschalier A, Delmas P, Busserolles J. Nav1.9 channel contributes to mechanical and heat pain hypersensitivity induced by subacute and chronic inflammation. PLoS ONE. 2011;6(8):e23083. https:\/\/doi.org\/10.1371\/journal.pone.0023083","journal-title":"PLoS ONE"},{"issue":"5","key":"1472_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1212\/WNL.0000000000002333","volume":"86","author":"C Han","year":"2016","unstructured":"Han C, Huang J, Waxman SG. Sodium channel Nav1.8: Emerging links to human disease. Neurology. 2016;86(5):473\u201383. https:\/\/doi.org\/10.1212\/WNL.0000000000002333","journal-title":"Neurology"},{"issue":"20","key":"1472_CR14","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1523\/JNEUROSCI.3799-16.2017","volume":"37","author":"AH Klein","year":"2017","unstructured":"Klein AH, Vyshnevska A, Hartke TV, De Col R, Mankowski JL, Turnquist B, Bosmans F, Reeh PW, Schmelz M, Carr RW, Ringkamp M. Sodium Channel Nav1.8 Underlies TTX-Resistant Axonal Action Potential Conduction in Somatosensory C-Fibers of Distal Cutaneous Nerves. J Neurosci. 2017;37(20):5204\u201314.","journal-title":"J Neurosci"},{"issue":"5","key":"1472_CR15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.pain.2014.01.012","volume":"155","author":"SR Garrison","year":"2014","unstructured":"Garrison SR, Weyer AD, Barabas ME, Beutler BA, Stucky CL. A gain-of-function voltage-gated sodium channel 1.8 mutation drives intense hyperexcitability of A- and C-fiber neurons. Pain. 2014;155(5):896\u2013905. https:\/\/doi.org\/10.1016\/j.pain.2014.01.012. Epub 2014 Jan 18. PMID: 24447515; PMCID: PMC3989381.","journal-title":"Pain"},{"key":"1472_CR16","doi-asserted-by":"publisher","unstructured":"Laird JM, Souslova V, Wood JN, Cervero F. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS\/PN3)-null mice. J Neurosci. 2002;22(19):8352-6. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-19-08352","DOI":"10.1523\/JNEUROSCI.22-19-08352"},{"issue":"1","key":"1472_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2009.11.023","volume":"208","author":"S Leo","year":"2010","unstructured":"Leo S, D\u2019Hooge R, Meert T. Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice. Behav Brain Res. 2010;208(1):149\u201357.","journal-title":"Behav Brain Res"},{"issue":"10","key":"1472_CR18","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1111\/bph.13092","volume":"172","author":"CE Payne","year":"2015","unstructured":"Payne CE, Brown AR, Theile JW, Loucif AJ, Alexandrou AJ, Fuller MD, Mahoney JH, Antonio BM, Gerlach AC, Printzenhoff DM, Prime RL, Stockbridge G, Kirkup AJ, Bannon AW, England S, Chapman ML, Bagal S, Roeloffs R, Anand U, Anand P, Bungay PJ, Kemp M, Butt RP, Stevens EB. A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability. Br J Pharmacol. 2015;172(10):2654\u201370. https:\/\/doi.org\/10.1111\/bph.13092","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1472_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/jm070637u","volume":"51","author":"ME Kort","year":"2008","unstructured":"Kort ME, Drizin I, Gregg RJ, Scanio MJ, Shi L, Gross MF, Atkinson RN, Johnson MS, Pacofsky GJ, Thomas JB, Carroll WA, Krambis MJ, Liu D, Shieh CC, Zhang X, Hernandez G, Mikusa JP, Zhong C, Joshi S, Honore P, Roeloffs R, Marsh KC, Murray BP, Liu J, Werness S, Faltynek CR, Krafte DS, Jarvis MF, Chapman ML, Marron BE. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain. J Med Chem. 2008;51(3):407\u201316. https:\/\/doi.org\/10.1021\/jm070637u","journal-title":"J Med Chem"},{"key":"1472_CR20","doi-asserted-by":"publisher","unstructured":"Banh C, Sic A, Knezevic NN. Sodium channel inhibitors in clinical development for pain management: a focused review. CNS Drugs. 2025 Nov 3. https:\/\/doi.org\/10.1007\/s40263-025-01244-x","DOI":"10.1007\/s40263-025-01244-x"},{"key":"1472_CR21","doi-asserted-by":"publisher","first-page":"RP90960","DOI":"10.7554\/eLife.90960","volume":"12","author":"YF Xie","year":"2024","unstructured":"Xie YF, Yang J, Ratt\u00e9 S, Prescott SA. Similar excitability through different sodium channels and implications for the analgesic efficacy of selective drugs. Elife. 2024;12:RP90960. https:\/\/doi.org\/10.7554\/eLife.90960","journal-title":"Elife"},{"issue":"22","key":"1472_CR22","doi-asserted-by":"publisher","first-page":"e2503570122","DOI":"10.1073\/pnas.2503570122","volume":"122","author":"RG Stewart","year":"2025","unstructured":"Stewart RG, Osorno T, Fujita A, Jo S, Ferraiuolo A, Carlin K, Bean BP. Modulation of human dorsal root ganglion neuron firing by the Nav1.8 inhibitor suzetrigine. Proc Natl Acad Sci U S A. 2025;122(22):e2503570122. https:\/\/doi.org\/10.1073\/pnas.2503570122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1472_CR23","doi-asserted-by":"publisher","unstructured":"Browne LE, Clare JJ, Wray D. Functional and pharmacological properties of human and rat NaV1.8 channels. Neuropharmacology. 2009;56(5):905\u2009\u2013\u200914. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.01.018","DOI":"10.1016\/j.neuropharm.2009.01.018"},{"issue":"20","key":"1472_CR24","doi-asserted-by":"publisher","first-page":"9865","DOI":"10.3390\/ijms26209865","volume":"26","author":"A Pham","year":"2025","unstructured":"Pham A, Yep H, Wozniak S, Javvaji A, Nada E, Bergese S. Beyond Opioids: A Review of Suzetrigine for Acute Pain Management. Int J Mol Sci. 2025;26(20):9865. https:\/\/doi.org\/10.3390\/ijms26209865","journal-title":"Int J Mol Sci"},{"key":"1472_CR25","doi-asserted-by":"publisher","unstructured":"Hemme J, Hijma PS, Siebenga ML, de Kam GJ, Groeneveld A. August Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults, Pain Medicine, 22, Issue 8, 2021, Pages 1814\u201326, https:\/\/doi.org\/10.1093\/pm\/pnab032","DOI":"10.1093\/pm\/pnab032"},{"issue":"Pt 2","key":"1472_CR26","doi-asserted-by":"publisher","first-page":"118326","DOI":"10.1016\/j.ejmech.2025.118326","volume":"302","author":"Z Wu","year":"2026","unstructured":"Wu Z, Lu D. Advances in the discovery of selective NaV1.8 inhibitors for pain management. Eur J Med Chem. 2026;302(Pt 2):118326. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118326.","journal-title":"Eur J Med Chem"},{"issue":"20","key":"1472_CR27","doi-asserted-by":"publisher","first-page":"8520","DOI":"10.1073\/pnas.0611364104","volume":"104","author":"MF Jarvis","year":"2007","unstructured":"Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A. 2007;104(20):8520\u20135. https:\/\/doi.org\/10.1073\/pnas.0611364104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1472_CR28","first-page":"1085","volume":"142","author":"T Bertoch","year":"2025","unstructured":"Bertoch T, D\u2019Aunno D, McCoun J, Solanki D, Taber L, Urban J, Oswald J, Swisher MW, Tian S, Miao X, Correll DJ, Negulescu P, Bozic C, Weiner SG. Suzetrigine, a Nonopioid Na V 1.8 Inhibitor for Treatment of Moderate-to-severe Acute Pain: Two Phase 3 Randomized Clinical Trials. Anesthesiology. 2025;142(6):1085\u201399.","journal-title":"Anesthesiology"},{"issue":"4","key":"1472_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.bja.2025.07.043","volume":"135","author":"N Attal","year":"2025","unstructured":"Attal N, Barrot M. Targeting Nav1.8 with the nonopioid antagonist suzetrigine for analgesia: cause for optimism? Br J Anaesth. 2025;135(4):829\u201332. https:\/\/doi.org\/10.1016\/j.bja.2025.07.043","journal-title":"Br J Anaesth"},{"issue":"1","key":"1472_CR30","doi-asserted-by":"publisher","first-page":"e001431","DOI":"10.1136\/bmjmed-2025-001431","volume":"4","author":"J Karri","year":"2025","unstructured":"Karri J, D\u2019Souza RS, Cohen SP. Between promise and peril: role of suzetrigine as a non-opioid analgesic. BMJ Med. 2025;4(1):e001431. https:\/\/doi.org\/10.1136\/bmjmed-2025-001431","journal-title":"BMJ Med"},{"key":"1472_CR31","doi-asserted-by":"publisher","unstructured":"Bennett DL, Clark AJ, Huang J, Waxman SG, Dib-Hajj SD. The Role of Voltage-Gated Sodium Channels in Pain Signaling. Physiol Rev. 2019;99(2):1079\u20131151. https:\/\/doi.org\/10.1152\/physrev.00052.2017","DOI":"10.1152\/physrev.00052.2017"},{"issue":"11","key":"1472_CR32","doi-asserted-by":"publisher","first-page":"e70414","DOI":"10.1111\/cts.70414","volume":"18","author":"R Rajasingham","year":"2025","unstructured":"Rajasingham R, Qi Y. Suzetrigine, a Non-Opioid Small-Molecule Analgesic: Mechanism of Action, Clinical, and Translational Science. Clin Transl Sci. 2025;18(11):e70414. https:\/\/doi.org\/10.1111\/cts.70414","journal-title":"Clin Transl Sci"},{"issue":"9","key":"1472_CR33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895\u2013926. https:\/\/doi.org\/10.1016\/j.jpain.2009.06.012","journal-title":"J Pain"},{"issue":"3","key":"1472_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/1440-1681.13610","volume":"49","author":"B Szulczyk","year":"2022","unstructured":"Szulczyk B, Pasierski M, Gawlak M. Prefrontal cortex pyramidal neurons express functional Nav1.8 tetrodotoxin-resistant sodium currents. Clin Exp Pharmacol Physiol. 2022;49(3):350\u20139. https:\/\/doi.org\/10.1111\/1440-1681.13610","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"11","key":"1472_CR35","doi-asserted-by":"publisher","first-page":"e71545","DOI":"10.1002\/hsr2.71545","volume":"8","author":"AL Mohiuddin","year":"2025","unstructured":"Mohiuddin AL, Ahmed Z. Suzetrigine - A Novel FDA-Approved Analgesic - Opportunities, Challenges and Future Perspectives: A Perspective Review. Health Sci Rep. 2025;8(11):e71545. https:\/\/doi.org\/10.1002\/hsr2.71545","journal-title":"Health Sci Rep"},{"issue":"7","key":"1472_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.18553\/jmcp.2025.31.7.729","volume":"31","author":"D Nikitin","year":"2025","unstructured":"Nikitin D, Rind DM, McQueen B, et al. The effectiveness and value of suzetrigine for moderate to severe acute pain: A summary from the Institute for Clinical and Economic Review\u2019s Midwest Comparative Effectiveness Public Advisory Council. J Manag Care Spec Pharm. 2025;31(7):729\u201334. https:\/\/doi.org\/10.18553\/jmcp.2025.31.7.729.","journal-title":"J Manag Care Spec Pharm"},{"key":"1472_CR37","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases. 2012\u2013. Suzetrigine. Updated May 10, 2025. Accessed 28 Nov 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK615315\/"},{"key":"1472_CR38","unstructured":"InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG). 2006-. Using medication: Learn More \u2013 The safe use of over-the-counter painkillers. [Updated 2021 Aug 23]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK361006\/"},{"issue":"3","key":"1472_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/phar.2666","volume":"42","author":"CH Yiu","year":"2022","unstructured":"Yiu CH, Vitharana N, Gnjidic D, Patanwala AE, Fong I, Rimington J, Begley D, Bugeja B, Penm J. Patient risk factors for opioid-related adverse drug events in hospitalized patients: A systematic review. Pharmacotherapy. 2022;42(3):194\u2013215. https:\/\/doi.org\/10.1002\/phar.2666","journal-title":"Pharmacotherapy"},{"key":"1472_CR40","doi-asserted-by":"publisher","unstructured":"Suzetrigine (Journavx) - a sodium channel blocker for acute pain, editor. Med Lett Drugs Ther. 2025;67(1723):33\u201335. https:\/\/doi.org\/10.58347\/tml.2025.1723a","DOI":"10.58347\/tml.2025.1723a"},{"key":"1472_CR41","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.2147\/JPR.S475351","volume":"17","author":"M Karcz","year":"2024","unstructured":"Karcz M, Abd-Elsayed A, Chakravarthy K, Aman MM, Strand N, Malinowski MN, et al. Pathophysiology of Pain and Mechanisms of Neuromodulation: A Narrative Review (A Neuron Project). J Pain Res. 2024;17:3757\u201390. https:\/\/doi.org\/10.2147\/JPR.S475351.","journal-title":"J Pain Res"},{"key":"1472_CR42","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1172\/JCI42843","volume":"120","author":"AE Dubin","year":"2010","unstructured":"Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120:3760\u201372. https:\/\/doi.org\/10.1172\/JCI42843.","journal-title":"J Clin Invest"},{"key":"1472_CR43","doi-asserted-by":"publisher","unstructured":"Elleman AV, Du Bois J. Chemical and Biological Tools for the Study of Voltage-Gated Sodium Channels in Electrogenesis and Nociception. ChemBioChem. 2022;23. https:\/\/doi.org\/10.1002\/cbic.202100625.","DOI":"10.1002\/cbic.202100625"},{"key":"1472_CR44","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4062\/biomolther.2025.046","volume":"33","author":"M AlDoughaim","year":"2025","unstructured":"AlDoughaim M, AlSuhebany N, AlZahrani M, AlDairem A, Alghamdi SS. Transforming Pain Management: Suzetrigine, a Novel Non-Opioid Analgesic. Biomol Ther (Seoul). 2025;33:934\u20139. https:\/\/doi.org\/10.4062\/biomolther.2025.046.","journal-title":"Biomol Ther (Seoul)"},{"key":"1472_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/9195","volume":"2","author":"AN Akopian","year":"1999","unstructured":"Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, et al. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci. 1999;2:541\u20138. https:\/\/doi.org\/10.1038\/9195.","journal-title":"Nat Neurosci"},{"key":"1472_CR46","doi-asserted-by":"publisher","unstructured":"Wood JN, Yan N, Huang J, Zhao J, Akopian A, Cox JJ, et al. Sensory neuron sodium channels as pain targets; from cocaine to Journavx (VX-548, suzetrigine). J Gen Physiol. 2025;157. https:\/\/doi.org\/10.1085\/jgp.202513778.","DOI":"10.1085\/jgp.202513778"},{"key":"1472_CR47","doi-asserted-by":"publisher","unstructured":"Daou I, Beaudry H, Ase AR, Wieskopf JS, Ribeiro-da-Silva A, Mogil JS, et al. Optogenetic Silencing of Na v 1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain. eNeuro. 2016;3. https:\/\/doi.org\/10.1523\/ENEURO.0140-15.2016.","DOI":"10.1523\/ENEURO.0140-15.2016"},{"key":"1472_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12974-015-0441-2","volume":"12","author":"F Yang","year":"2015","unstructured":"Yang F, Sun W, Yang Y, Wang Y, Li C-L, Fu H, et al. SDF1\u2013CXCR4 signaling contributes to persistent pain and hypersensitivity via regulating excitability of primary nociceptive neurons: involvement of ERK-dependent Nav1.8 up-regulation. J Neuroinflammation. 2015;12:219. https:\/\/doi.org\/10.1186\/s12974-015-0441-2.","journal-title":"J Neuroinflammation"},{"key":"1472_CR49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40122-024-00697-0","volume":"14","author":"JD Osteen","year":"2025","unstructured":"Osteen JD, Immani S, Tapley TL, Indersmitten T, Hurst NW, Healey T, et al. Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain. Pain Ther. 2025;14:655\u201374. https:\/\/doi.org\/10.1007\/s40122-024-00697-0.","journal-title":"Pain Ther"},{"key":"1472_CR50","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1097\/j.pain.0000000000003639","volume":"166","author":"EA Gordon","year":"2025","unstructured":"Gordon EA, Tyagi S, Dib-Hajj SD, Bennett DL. Selective targeting of voltage-gated sodium channels to achieve analgesia: current status and future directions. Pain. 2025;166:S42\u20136. https:\/\/doi.org\/10.1097\/j.pain.0000000000003639.","journal-title":"Pain"},{"key":"1472_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa2209870","volume":"389","author":"J Jones","year":"2023","unstructured":"Jones J, Correll DJ, Lechner SM, Jazic I, Miao X, Shaw D, et al. Selective Inhibition of Na V 1.8 with VX-548 for Acute Pain. N Engl J Med. 2023;389:393\u2013405. https:\/\/doi.org\/10.1056\/NEJMoa2209870.","journal-title":"N Engl J Med"},{"key":"1472_CR52","unstructured":"Vertex Pharmaceuticals Incorporated, Phase A. Updated 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy. ClinicalTrials.gov Identifier NCT05553366. https:\/\/clinicaltrials.gov\/study\/NCT05553366. 2025. Accessed 2 Jan 2026."},{"key":"1472_CR53","unstructured":"Vertex Pharmaceuticals Incorporated, Phase A. Updated 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of VX-548 for Acute Pain After Full Abdominoplasty. ClinicalTrials.gov Identifier NCT05558410. https:\/\/clinicaltrials.gov\/study\/NCT05558410. 2025. Accessed 2 Jan 2026."},{"key":"1472_CR54","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40265-025-02178-w","volume":"85","author":"SJ Keam","year":"2025","unstructured":"Keam SJ, Suzetrigine. First Approval Drugs. 2025;85:845\u201351. https:\/\/doi.org\/10.1007\/s40265-025-02178-w.","journal-title":"First Approval Drugs"},{"key":"1472_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/ddc4030032","volume":"4","author":"M Jones","year":"2025","unstructured":"Jones M, Demery A, Al-Horani RA, Suzetrigine. A Novel Non-Opioid Analgesic for Acute Pain Management\u2014A Review. Drugs Drug Candidates. 2025;4:32. https:\/\/doi.org\/10.3390\/ddc4030032.","journal-title":"Drugs Drug Candidates"},{"key":"1472_CR56","unstructured":"Vertex Pharmaceuticals Inc. Suzetrigine: US prescribing information. 2025. https:\/\/www.journavx.com\/. Accessed 7 Dec 2025."},{"key":"1472_CR57","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90755","author":"M Mach","year":"2025","unstructured":"Mach M, Giba A, Miedziaszczyk M, Bryla A, Szkutnik-Fiedler D. Suzetrigine as a Novel Non-opioid Analgesic Drug in Pain Management: A Review of Clinical Evidence and Therapeutic Perspectives. Cureus. 2025. https:\/\/doi.org\/10.7759\/cureus.90755.","journal-title":"Cureus"},{"issue":"47","key":"1472_CR58","doi-asserted-by":"publisher","first-page":"19444","DOI":"10.1073\/pnas.1216080109","volume":"109","author":"CG Faber","year":"2012","unstructured":"Faber CG, Lauria G, Merkies IS, Cheng X, Han C, Ahn HS, Persson AK, Hoeijmakers JG, Gerrits MM, Pierro T, Lombardi R, Kapetis D, Dib-Hajj SD, Waxman SG. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A. 2012;109(47):19444\u20139. https:\/\/doi.org\/10.1073\/pnas.1216080109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1472_CR59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jocn.2015.05.071","volume":"26","author":"R Dabby","year":"2016","unstructured":"Dabby R, Sadeh M, Broitman Y, Yosovich K, Dickman R, Leshinsky-Silver E. Painful small fiber neuropathy with gastroparesis: A new phenotype with a novel mutation in the SCN10A gene. J Clin Neurosci. 2016;26:84\u20138.","journal-title":"J Clin Neurosci"},{"issue":"9","key":"1472_CR60","doi-asserted-by":"publisher","first-page":"e0161789","DOI":"10.1371\/journal.pone.0161789","volume":"11","author":"AM Kist","year":"2016","unstructured":"Kist AM, Sagafos D, Rush AM, Neacsu C, Eberhardt E, Schmidt R, Lunden LK, \u00d8rstavik K, Kaluza L, Meents J, Zhang Z, Carr TH, Salter H, Malinowsky D, Wollberg P, Krupp J, Kleggetveit IP, Schmelz M, J\u00f8rum E, Lampert A, Namer B. SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing. PLoS ONE. 2016;11(9):e0161789. https:\/\/doi.org\/10.1371\/journal.pone.0161789","journal-title":"PLoS ONE"},{"key":"1472_CR61","doi-asserted-by":"publisher","first-page":"174480691666608","DOI":"10.1177\/1744806916666083","volume":"12","author":"G Duan","year":"2016","unstructured":"Duan G, Han C, Wang Q, Guo S, Zhang Y, Ying Y, Huang P, Zhang L, Macala L, Shah P, Zhang M, Li N, Dib-Hajj SD, Waxman SG, Zhang X. A SCN10A SNP biases human pain sensitivity. Mol Pain. 2016;12:1744806916666083.","journal-title":"Mol Pain"},{"key":"1472_CR62","doi-asserted-by":"publisher","first-page":"117697","DOI":"10.1016\/j.ejmech.2025.117697","volume":"293","author":"N Li","year":"2025","unstructured":"Li N, Wang L, Hu X, Xu H, Yang B, Zhan L, Cai Y, Gu Y, Chen X, Zheng Y, Liu T, Gao Z, Xiong B. Conformational restriction enables discovering a series of chroman derivatives as potent and selective NaV1.8 inhibitors with improved pharmacokinetic properties. Eur J Med Chem. 2025;293:117697. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117697","journal-title":"Eur J Med Chem"},{"issue":"1","key":"1472_CR63","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-024-55764-z","volume":"16","author":"B Neumann","year":"2025","unstructured":"Neumann B, McCarthy S, Gonen S. Structural basis of inhibition of human NaV1.8 by the tarantula venom peptide Protoxin-I. Nat Commun. 2025;16(1):1459. https:\/\/doi.org\/10.1038\/s41467-024-55764-z","journal-title":"Nat Commun"},{"issue":"5","key":"1472_CR64","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1124\/pharmrev.123.000923","volume":"76","author":"S Pei","year":"2024","unstructured":"Pei S, Wang N, Mei Z, Zhangsun D, Craik DJ, McIntosh JM, Zhu X, Luo S. Conotoxins Targeting Voltage-Gated Sodium Ion Channels. Pharmacol Rev. 2024;76(5):828\u201345. https:\/\/doi.org\/10.1124\/pharmrev.123.000923","journal-title":"Pharmacol Rev"},{"issue":"11","key":"1472_CR65","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/toxins10110483","volume":"10","author":"D Stepensky","year":"2018","unstructured":"Stepensky D, Toxins. (Basel). 2018;10(11):483. https:\/\/doi.org\/10.3390\/toxins10110483","journal-title":"(Basel)"},{"issue":"1","key":"1472_CR66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13041-025-01253-3","volume":"18","author":"MY Ali","year":"2025","unstructured":"Ali MY, Antunes FTT, Huang S, Chen L, Zamponi GW. Pharmacological inhibition of NaV1.8 by suzetrigine reveals potent analgesic potential without tolerance development in mice. Mol Brain. 2025;18(1):86. https:\/\/doi.org\/10.1186\/s13041-025-01253-3","journal-title":"Mol Brain"},{"key":"1472_CR67","unstructured":"U.S. National Library of Medicine. JOURNAVX (suzetrigine) [prescribing information]. DailyMed. Updated 2025. Accessed 2025. Available at: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f0976da4-1d20-4517-945c-b60ed2f41c12"},{"key":"1472_CR68","doi-asserted-by":"publisher","unstructured":"Gilchrist JM, Yang ND, Jiang V, Moyer BD. Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action. Mol Pharmacol. 2024;105(3):233\u2013249. https:\/\/doi.org\/10.1124\/molpharm.123.000789. PMID: 38195157.","DOI":"10.1124\/molpharm.123.000789"},{"key":"1472_CR69","doi-asserted-by":"publisher","unstructured":"Robinson M, Wettschurack K, Halurkar MS, Chen X, Zhang Z, Zhang J, Yang Y. Precision medicine for sodium channelopathy-related autism and epilepsy. Trends Mol Med. 2025 Oct 28:S1471-4914(25)00216-3. https:\/\/doi.org\/10.1016\/j.molmed.2025.09.007","DOI":"10.1016\/j.molmed.2025.09.007"},{"key":"1472_CR70","doi-asserted-by":"publisher","unstructured":"Jianguo C, Suzetrigine FDA, Approval. A Transformative Milestone in Pain Management. Transl Perioper Pain Med. 2025;12. https:\/\/doi.org\/10.31480\/2330-4871\/200.","DOI":"10.31480\/2330-4871\/200"},{"key":"1472_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.63096\/medtigo3067115","volume":"1","author":"S Srinivasan","year":"2025","unstructured":"Srinivasan S. Suzetrigine and the Future of Non-Addictive Pain Management in the Midst of the U.S. Opioid Epidemic. medtigo J Med. 2025;1:1\u20135. https:\/\/doi.org\/10.63096\/medtigo3067115.","journal-title":"medtigo J Med"},{"key":"1472_CR72","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1038\/s41467-021-22841-6","volume":"12","author":"J Filtjens","year":"2021","unstructured":"Filtjens J, Roger A, Quatrini L, Wieduwild E, Gouilly J, Hoeffel G, et al. Nociceptive sensory neurons promote CD8 T cell responses to HSV-1 infection. Nat Commun. 2021;12:2936. https:\/\/doi.org\/10.1038\/s41467-021-22841-6.","journal-title":"Nat Commun"},{"key":"1472_CR73","doi-asserted-by":"publisher","first-page":"118180","DOI":"10.1016\/j.bmc.2025.118180","volume":"128","author":"Z Dong","year":"2025","unstructured":"Dong Z, Xiong B, Sun T, Jiang R, Feng F, Sun H. Brief analysis of Nav1.7 inhibitors: Mechanism of action and new research trends. Bioorg Med Chem. 2025;128:118180. https:\/\/doi.org\/10.1016\/j.bmc.2025.118180.","journal-title":"Bioorg Med Chem"},{"key":"1472_CR74","doi-asserted-by":"publisher","first-page":"115806","DOI":"10.1016\/j.ejmech.2023.115806","volume":"261","author":"K Zhu","year":"2023","unstructured":"Zhu K, Wang L, Liao T, Li W, Zhou J, You Y, et al. Progress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management. Eur J Med Chem. 2023;261:115806. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115806.","journal-title":"Eur J Med Chem"},{"key":"1472_CR75","doi-asserted-by":"publisher","first-page":"13979","DOI":"10.3390\/ijms241813979","volume":"24","author":"A Bonura","year":"2023","unstructured":"Bonura A, Brunelli N, Marcosano M, Iaccarino G, Fofi L, Vernieri F, et al. Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles\u2014A Narrative Review. Int J Mol Sci. 2023;24:13979. https:\/\/doi.org\/10.3390\/ijms241813979.","journal-title":"Int J Mol Sci"},{"key":"1472_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/anesthres2030018","volume":"2","author":"M Wu","year":"2025","unstructured":"Wu M, Park B, Chu X-P. Nociceptin and the NOP Receptor in Pain Management: From Molecular Insights to Clinical Applications. Anesth Res. 2025;2:18. https:\/\/doi.org\/10.3390\/anesthres2030018.","journal-title":"Anesth Res"},{"issue":"1","key":"1472_CR77","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/FBP.0000000000000422","volume":"30","author":"JT da Silva","year":"2019","unstructured":"da Silva JT, Evangelista BG, Venega RAG, Seminowicz DA, Chacur M. Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats. Behav Pharmacol. 2019;30(1):79\u201388.","journal-title":"Behav Pharmacol"},{"key":"1472_CR78","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.2147\/JPR.S302004","volume":"14","author":"S Bimonte","year":"2021","unstructured":"Bimonte S, Cascella M, Forte CA, Esposito G, Cuomo A. The Role of Anti-Nerve Growth Factor Monoclonal Antibodies in the Control of Chronic Cancer and Non-Cancer Pain. J Pain Res. 2021;14:1959\u201367. https:\/\/doi.org\/10.2147\/JPR.S302004. Published 2021 Jun 28.","journal-title":"J Pain Res"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-026-01472-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:03:37Z","timestamp":1773774217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-026-01472-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1007\/s11916-026-01472-w","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Alaa Abd-Elsayed is an Editorial Board Member of Pain and Therapy. Alaa Abd-Elsayed was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Alaa Abd-Elsayed is also a consultant for Medtronic, Curonix, Avanos, and Averitas.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}